Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Bourdeaut

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
Oncotarget|April 22, 2017
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancersWilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, et al.
Journal of Neuro-Oncology|March 3, 2022
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patientsCharles de Marcellus, Arnault Tauziède-Espariat, Aurélie Cuinet, et al.
Neuro-Oncology|November 30, 2017
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosisLéa Guerrini-Rousseau, Christelle Dufour, Pascale Varlet, et al.
Pediatric Blood & Cancer|November 30, 2016
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumorsThomas Pincez, Nathalie Clément, Eve Lapouble, et al.
EMBO Molecular Medicine|July 23, 2019
An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastomaMorgane Morabito, Magalie Larcher, Florence Mg Cavalli, et al.
Cell Reports|November 16, 2017
High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid TumorsCéline Chauvin, Amaury Leruste, Arnault Tauziede-Espariat, et al.
Familial Cancer|September 5, 2020
Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working GroupSimone Hettmer, Guillaume Dachy, Guido Seitz, et al.
Hormone Research in Paediatrics|November 8, 2014
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndromeLaura González Briceño, Jacques Grill, Franck Bourdeaut, et al.
JCO Precision Oncology|September 17, 2025
Rare Variants Associated With Pediatric Cancer Treatment-Related Second Malignant Neoplasm RiskClaire Ducos, Brice Fresneau, Filippo Rosselli, et al.
Pediatric Blood & Cancer|October 2, 2019
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohortMartin Benesch, Karolina Nemes, Petra Neumayer, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Oncotarget|April 22, 2017
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancersWilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, et al.
Journal of Neuro-Oncology|March 3, 2022
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patientsCharles de Marcellus, Arnault Tauziède-Espariat, Aurélie Cuinet, et al.
Neuro-Oncology|November 30, 2017
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosisLéa Guerrini-Rousseau, Christelle Dufour, Pascale Varlet, et al.
Pediatric Blood & Cancer|November 30, 2016
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumorsThomas Pincez, Nathalie Clément, Eve Lapouble, et al.
EMBO Molecular Medicine|July 23, 2019
An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastomaMorgane Morabito, Magalie Larcher, Florence Mg Cavalli, et al.
Cell Reports|November 16, 2017
High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid TumorsCéline Chauvin, Amaury Leruste, Arnault Tauziede-Espariat, et al.
Familial Cancer|September 5, 2020
Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working GroupSimone Hettmer, Guillaume Dachy, Guido Seitz, et al.
Hormone Research in Paediatrics|November 8, 2014
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndromeLaura González Briceño, Jacques Grill, Franck Bourdeaut, et al.
JCO Precision Oncology|September 17, 2025
Rare Variants Associated With Pediatric Cancer Treatment-Related Second Malignant Neoplasm RiskClaire Ducos, Brice Fresneau, Filippo Rosselli, et al.
Pediatric Blood & Cancer|October 2, 2019
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohortMartin Benesch, Karolina Nemes, Petra Neumayer, et al.
Pageof 18